Anat Cell Biol 2020; 53(4): 481-492
Published online December 31, 2020
Copyright © Korean Association of ANATOMISTS.
1Department of Anatomy, Faculty of Science, Mahidol University, Bangkok, 2Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand
Correspondence to:Kamonwan Jongsomchai
Department of Anatomy, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
Prostate cancer is one of the high incidences and the most invasive cancer that is also highly resistant to chemotherapy. Currently, several natural products have been considering using as the supplements for anti-cancer therapy. This study aims to identify the potential active anti-cancer ingredients in the bran extracts of the native Thai rice (
Keywords: Anthocyanins, Anticancer, β-catenin, Epithelial mesenchymal transition, Snail
Black rice and rice bran have beneficial health effects in human due to its anthocyanins, a phenolic compound in the flavonoid family, and phytosterol compositions [1-4]. Anthocyanins derived from the black rice recognized for their antioxidant properties that can play a significant role in cancer prevention . Anthocyanins inhibit many human cancer cells included tongue carcinoma (SCC-4), hepatocellular carcinoma (Huh-7), and cervical carcinoma (HeLa) through the induction of apoptosis, anti-angiogenesis and anti-invasiveness . The anti-invasion effects of anthocyanins are correlated with the repression of proteolytic enzymes; matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) or urokinase-plasminogen activator (u-PA)  that the transformed cells secret to assist their invasive and migratory capabilities. Although not derived from rice, anthocyanin- and proanthocyanidin-enriched fractions from blueberry (
Prostate cancer is one of the most common solid organ cancers that cause a high mortality rate worldwide. The cancer forms and develops slowly in the adult males under the influencing of genetic and environmental factor. Once developed, the cancer becomes one of the most metastatic cancers that has no specific treatment and often resistant to chemotherapy and radiotherapy . Previously, research studies have purposed the alternative treatment by the usage of several plant extracts and plant-derived bioactive compounds that shown the
Accumulative data revealed that at the initial stage of cancer development, the abnormal prostate cells switch phenotype from the polarized epithelial cells to the mesenchymal phenotype. This EMT is facilitated by the loss of cell adhesion molecule, E-cadherin, and the translocation of β-catenin linkage protein from the cytoplasm into the nucleus [21, 22]. EMT characteristic is allowed for cell movement, and E-cadherin loss appears to be an important step in the invasion and metastasis of cancers. Significant down-regulation of E-cadherin expression during EMT process allows this molecule to be used as a molecular marker of EMT . EMT is also involved in progressive redistribution of mesenchymal molecules, such as vimentin and N-cadherin [23-25]. The over-expression of vimentin occurs during EMT allowing this molecule to be used as a molecular marker of EMT. Previously, studies in the
The dark purple glutinous rice (
Human prostate carcinoma cells (PC3) was commercial purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). According to the source, the cells were poor-differentiated adenocarcinoma (neoplastic cell of epithelial origin), having highly metastatic potential. This PC3 cells do not respond to androgens, glucocorticoids or fibroblast growth factors, but are influence by EGF. The cells were cultured in modified Dulbecco’s Modified Eagle F12 Medium (DMEM-F12) (Gibco, Dublin, Ireland) supplemented with 10% fetal bovine serum (FBS; Gibco), 0.1% streptomycin-penicillin, 1% sodium pyruvate, 1% non-essential amino acid and 3.7 g/l of sodium bicarbonate (NaHCO3) as pH buffer agent. The cells were incubated in a 75-cm3 T flask (Corning, NY, USA) under humidified air with 5% CO2 incubator at 37°C.
PC3 cells were cultured in a 96-well plate at a density of 1.8×105 cells/well in 100 µl of DMEM-F12 medium (with 5% FBS) for 24 hours. Then, treated with varied concentrations of LBM, the sub-fractions or the purified fraction for 24, 48, and 72 hours. Water grade I was as vehicle control. After incubation at 24 and 48 hours, the media was removed and 100 μl of PBS containing 10 μl of MTT solution (Sigma-Aldrich, St. Louis, MO, USA) was added, and incubation was continued at 37°C for 4 hours, then replaced with MTT solubilizing solution (100 μl). The color reaction was measured using spectrophotometry, at 570 nm with the reference wavelength at 690 nm. Cell viability calculation was from percentage of survival in the treated and untreated groups.
PC3 cells were cultured on FN-coated glass slide chamber (2×105 cells/well in 500 µl of medium free-serum) and incubated at 37°C, in 5% CO2 for 24 hours then, treated with each test sample for 48 hours. The treated-cells were 4% paraformaldehyde fixed for 20 minutes, and 15 minutes permeabilized with 0.1% Triton X-100 in PBS solution. Cells on cover slips were blocked with 5% BSA/0.25% Triton X-100 for 30 minutes, then co-incubated with 1:500–1:200 dilution of the primary antibodies, β-catenin, α-tubulin, vimentin, F-actin or pFAK (all from Cell Signaling, Danvers, MA, USA); Snail1/2 (Abcam, Cambridge, UK); or Smad2/3 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) in blocking solution, at 4°C overnight. They were then incubated with 1:1,000 dilution FITC-conjugated or Alexa Fluor 555 conjugated secondary antibodies in TBS for 1 hour, incubated with Alexa Fluor 488-Phalliodin for 15 minutes, washed and counter-stained with DAPI. Then, mounted cover slips on slides, and examined the slides by laser scanning confocal microscopy (Olympus FV1000; Olympus, Tokyo, Japan).
To potentiate cell attachment, PC3 cells were grown on fibronectin (FN)-coated plates (FN 5 μg/ml in PBS). A 2×105 cells/well PC3 cells were plated in 6 well culture plates and cultured in a humidified incubator for 24 hours. The cells were treated with LBM, the subsequent fractions, or RBC3G for 48 hours. The treated-cells were trypsinized with 0.25% Trypsin/EDTA and centrifuged at 4,000 rpm, 4°C for 5 minutes. The pellets were washed with cold PBS and RIPA buffer and the cell suspensions were transferred into the tubes, incubated on ice for 30 minutes, mixed and centrifuged at 15,000 rpm, 4°C, for 15 minutes. The supernatants were collected, and total protein concentrations were measured using BCA protein assay kit (Merck, Darmstadt, Germany). Proteins were separated using SDS-polyacrylamide gel, and transferred to nitrocellulose membrane (0.45 μm). The membrane was blocked with a 5% BSA solution for 2 hours before incubation with 1:1,000 dilution of the primary antibodies including; β-catenin, pFAK, vimentin, E-cadherin, MMP9, NF-kB (all from Cell Signaling); Snail1/2; or Smad2/3 overnight at 4°C. After washing, the membrane was incubated with HRP conjugated secondary antibodies for 90 minutes before being developed using ECL Prime Western Blotting Detection kit (BioRad, Hercules, CA, USA). Anti β-actin antibody was used to control for equal loading of proteins.
PC3 cells were cultured in 6-well FN-coated plates with serum free culture medium for 24 hours. The cells were treated with fresh serum free medium containing LBM (0, 250, and 500 µg/ml) or RBC3G (0, 10, and 50 μM) for 24 and 48 hours at 37°C. The conditioned media was collected and cold centrifuged at 3,500 rpm, for 10 minutes. The supernatant was collected and kept in lyophilized form. On assay, the samples were dissolved, and protein concentration was determined. An equal amount of protein was loaded with 2 times of non-reducing loading dye in gel, composed of 4% polyacrylamide stacking gel and 8% polyacrylamide separating gel, containing 0.8% gelatin w/v, 10%SDS PAGE. After electrophoresis, the gels were washed with 50 mM Tris-HCL pH 7.5, 5 mM CaCl2 and 2.5% (v/v) Triton X-100 for 30 minutes. The gel was incubated in buffer (0.05M Tris buffer, pH 7.5 containing 200 mM NaCl, 5 mM CaCl2 and 0.05% NaN3) at 37°C for 18 hours. Then, stained with 0.5% Coomassie brilliant blue R-250 in 5% methanol and 10% acetic acid for 2 hours and de-stained with solution containing 30% methanol and 10% acetic acid at room temperature until the clear bands of MMPs were observed. Protein standards were run to compare the approximate molecular weights that determine the MMPs subtypes.
PC3 cells were cultured in 6 well FN-coated plates with serum free culture medium for 24 hours. Monolayer cells were scratched with a pipette tip to create wounds. The plates were washed with PBS before treatment with various concentrations of the compound or fractions. After 24 and 48 hours incubation at 37°C, the culture supernatant was collected for enzymatic assay (gel zymography). Cell migration images were inspected and photographed under light microscopy. The number of migrating cells was analyzed by counting the total number of cells approaching the area between edges of the scratch wound.
PC3 cells were resuspended to 1.2×105 cells/μl in 500 ml of DMEM-F12 medium. The cells were treated with or without RBC3G (10 and 50 µM) or LBM2.2 (0.5 and 1 mg/ml) for 24 hours before plating onto the upper chamber of extracellular matrix pre-coated transwell plate (Corning Inc., Flintshire, UK). 20% FBS was added in the lower chamber of the wells to serve as a chemo-attractant. The cells were incubated for 24 hours at 37°C, under 5% CO2. After the incubation, the non-invaded cells were removed from the upper surface of the membrane. The invaded cells on the lower surface of the membrane were fixed with 25% methanol for 20 minutes and stained with 5% crystal violet for 15 minutes and counted.
One-way ANOVA, followed by Tukey
Cell viability assay by MTT showed that the LP rice bran crude extracts (LBMs) and their successive purified fractions possessed a time and concentration-dependent effect on PC3 cell, after 24 and 48 hours incubation (Fig. 1B). Among the three methanol extracts (LBM1, LBM2, and LBM3), LBM2 displayed the greatest inhibitory action on cell viability. At 48 hours incubation assay, LBM2 sub-fractions (LBM2.2 and LBM2.3) maintained their potency on cell viability. The successive LBM2.2 fraction, LBM2.2.2 displayed the highest concentration-dependent activity. After LBM2.2.2 was further fractionated by HPLC and LC/MS/MS a de-glycosylated (aglycone) form of anthocyanins, C3G was identified as a major constituent in the rice bran , the RBC3G was assessed to compare the potential effect with the commercial available C3G (Sigma-Aldrich). Both RBC3G and C3G displayed a similar result on PC3 cell viability at concentrations that reduced 50% cell survival (IC50; approximately 167.8±0.06 µM). To avoid the cytotoxic induced cell death effect, the experiments in this study were performed using RBC3G concentrations less than 100 µM.
The immuno-fluorescent studies illustrated the untreated control PC3 cells cultured on FN-coated plate that expressed an EMT signaling protein, β-catenin, in a clumping pattern around the perinuclear region (Fig. 2A, left row), while some distributed in a dotted/linear pattern, on the cell surface and/or the cell-cell adhesion area (Fig. 2B, left row). A profuse distribution of polymerized alpha-tubulin forming microtubules appeared in the cytoplasm (Fig. 2A, left row). Both suggested the potentially active cell motility. In addition, the immune-staining for F-actin cytoskeleton appeared on the cell surface was co-localized with its organizing protein, p-FAK, which was in a linear pattern and dotted pattern, respectively (Fig. 2B and C, left rows), suggesting the potentially active migration capability of PC3 cell. Treatment of PC3 cells with the RBC3G (Fig. 2, middle & right rows) demonstrated a concentration-dependent effect on the reduction of β-catenin (Fig. 2A and B, middle & right rows), F-actin (Fig. 2B and C, middle and right rows) and p-FAK (Fig. 2C, right row) immuno-intensity and alteration of their distribution patterns comparing to the untreated controls. The distribution of EMT associated-proteins; E-cadherin (epithelial phenotypic marker) and vimentin (mesenchymal phenotypic marker) in the untreated PC3 cells showed vimentin expression as a clump at the perinuclear area of almost every single cell (Fig. 2D, left row). RBC3G treatment, especially with 100 μM concentration, decreased vimentin positive cells and its staining pattern (Fig. 2D, right row). Unfortunately, attempts to demonstrate the expression of E-cadherin by immunofluorescent assay was unsatisfied (data not shown). The distribution of Smad proteins involved in classical signaling pathway for growth factor mediated cell proliferation, differentiation and migration in most cancer cells revealed that in the untreated PC3 cells (control), Smad2/3 immuno-fluorescent staining was distributed in nuclei as a dense aggregation complex (Fig. 2E, left row). RBC3G treatment significantly decreased the immuno-intensity of Smad2/3 in the nucleus and deccreased the number of Smad positive cells (Fig. 2E, right row), suggesting it’s active role in transcriptional regulaion of the cancer cells. In addition, expression of Snail, the downstream effectors of Smad, demonstrated a profuse Snail1/2 immuno-fluorescent staining localized in the nucleus and some distributed in the cytoplasm of the untreated PC3 cells (Fig. 2F, left row). Treatment of PC3 cells with high concentration RBC3G (100 μM) markedly reduced the distribution of Snail1/2 both in the nucleus and the cytoplasm (Fig. 2F, right row). These immuno-stained results were in good correlated with the Western blot analysis of β-catenin and p-FAK (Fig. 2G), Vimentin and E-cadherin (Fig. 2H), Smad2/3 and Snail1/2 (Fig. 2I and J) demonstrated the stage of PC3 cell transformation which could be inhibited with RBC3G.
Western blots analysis for proteins involved in metastasis and invasion; MMP-9 and NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells), revealed significant reduction of MMP-9 and NF-κB proteins production in PC3 cells treated with RBC3G in a concentration dependent manner (Fig. 3A). Assessment for the activity of matrix degradation enzyme that potentiate metastasis revealed significantly reduction of this matrix degradation enzyme MMP-9 also in a concentration-dependent manner (Fig. 3B).
Inhibition of cell migration and invasion
On Scratch/wound healing assay (Fig. 4A), treatment of monolayer cultured PC3 cells with RBC3G (10–50 µM) for 24–48 hours showed decreased cell migration toward the wound area in a concentration dependent manner. The counting number of PC3 cell migration toward the wound area was significant reduced, relative to the untreated controls. On the invasion assay (Fig. 4B), the invading cells showed a spindle fibroblast-like morphology. Treatment of the cells with RBC3G (10 and 50 µM) 24 hours before plating resulted in inhibition of the invasion capability of the cells through matrix gel-coated Transwell plates. The counting number of invaded cells showed significantly reduction of the treated cells compared to the control.
The results from this study identified cyanidine-3-glucoside in the Thai black rice bran (LP variety) as an anti-cancer agent that inhibited prostate cancer transformation and delay the progression of prostate cancer, including cell proliferation, transformation, migration, and invasion. This chemical isolated compound derived from successive purifying fractions of the Thai black rice bran, RBC3G, is primary presented in high amount as a natural aglycone form of anthocyanins that never been reported for constituents in this plant. The bioactive activities, specific compound properties and its mechanism of action that exerted on invasive prostate cancer PC3 cells is the anti-cancer progression. Previously, several studies had reported cyanindin-3-glucoside from fruits affecting carcinogenesis through many pathways. For example, it inhibits proliferation of human cancer cell lines by suppression of MAPK activity . It is a potent antioxidant, particularity against OH- and O2 radicals [5, 33]. Cyanindin-3-glucoside induces apoptosis of cancer cells via caspase-3 cleavage, DNA fragmentation via a Bcl-2/Bax pathway [17, 34], and induces cell cycle arrest via a cyclin dependent pathway . These pathways are primarily concentrated on induced apoptotic cell death, which remarked as criteria for a cancer therapeutic agent. However, the resulting cell death effect of several compounds is mostly from the high concentration of the compound under examined
The evident presented in this study clearly demonstrated that RBC3G decreased the percent PC3 cell survival in a concentration-dependent manner, reduced the expression of β-catenin and p-FAK, and induced cytoskeletal remodeling within the cells, leading to a delaying of cancer transformation process. The results were correlated well with the former observations showing that during this process, β-catenin, mostly distributed on the cell surface and in the perinuclear region, was dislodged from F-actin association and translocated from the cell adhesion junction, by the aid of cytoplasmic microtubules, into the nucleus [30, 36]. RBC3G inhibited both β-catenin expression and its chemical signaling cascade, thus inhibiting its dissociation and translocation from the cell periphery and playing significant roles in the signaling of cell differentiation through the process of EMT. Consequently, the data suggest that RBC3G reduces p-FAK expression in the PC3 cells and decreases its distribution at the cell periphery, which would reduce cell-matrix interaction. The immuno-labeled α-tubulin in the transformed PC3 cells reflected microtubule formation, indicating the high invasive potential of the cell. RBC3G reduces microtubule formation and appears to reduce the cell motility capability. Therefore, RBC3G could prevent the cell from successive migration and invasion. The anti-metastasis mechanism of RBC3G relative to PC3 cells defined through signaling inhibition of molecules essential to epithelial-mesenchymal transition.
To a better understanding of the detailed mechanism(s) by which RBC3G inhibits EMT, we studied the expression and distribution of Smad since Smad signaling pathway appears to be activating in prostate cancer PC3 cell. Both immunohistochemical and western blot analysis demonstrated that in addition to β-catenin reduction, the inhibition of EMT by RBC3G was associated with a reduction in Smad and Snail transcriptional factors. Smad signaling regulated by the growth factor receptor such as TGF-β, which activates the phosphorylation and formation of Smad complex and then moves into the nucleus to regulate the transcription of many genes [30, 31, 37]. We found that PC3 cell expressed high level of both Smad and Snail. The untreated PC3 cell displayed intense distribution of immunostaining for Smad2/3, mainly aggregated within the nucleus. RBC3G significantly reduced the Smad2/3 expression and diminished its nuclei localization, aa well as decreased the number of Smad positive cells. The cells also expressed high level of Snail, and Snail1/2 complex was found over the nucleus and in the cytoplasm. RBC3G treatment decreased the cytoplasmic distribution of Snail1/2, but did not reduced Snail1/2 concentrated in the nucleus. These data suggest that RBC3G inhibits translocation of β-catenin and Smad transcriptional factors into the nucleus, thus inhibiting EMT. Meanwhile, RBC3G treated PC3 cells reduced the Snail transcription and expression that was high during EMT development and cancer transformation leading to inhibition of E-cadherin . Relative to Snail expression by RBC3G, the current data indicate an alteration of expression level and distribution of E-cadherin and vimentin (tumor marker proteins) in the treated cells. Obviously, RBC3G significantly reduced vimentin expression (0.53–0.45 folds) and reduced vimentin immuno-intensity in the cells. As defined by Western blot analysis, RBC3G also increased the expression level of E-cadherin in the treated PC3 cells. The results suggest that RBC3G could effectively delay the cancer transformation process or it could potentially reverse prostate cancer cells conversion from mesenchymal to epithelial cell type. This consequence mechanism on cell differentiation never been explained before, but it associates with the previous study demonstrating that C3G potentiate diffentiation of PC3 and DU145 cells by increased the level of P75NGFR tumor suppressor leading the cells to normal-like cell phenotype Sorrenti et al. .
The effectiveness of RBC3G on delaying cancer progression exhibited by the significant reduction of MMP-9 enzyme levels, which correlated well with the reduction of NF-κB, a transcription factor associated with cell migration activation in PC3 cells. These inhibitory effects were resulted from the initial reduction of NF-κB expression and its signaling activity that subsequently suppressed MMP-9 production and decreased matrix degradation activity. RBC3G had anti-metastatic and anti-invasion effects on PC3 cell biological activity in the inhibition assays. This result agrees with previous studies that reported on other plants derived anthocyanins [1, 7, 33, 38-40]. Precisely, analysis for cellular responses suggests that the major phytochemical constituent in the RBC3G, possesses anti-cancer properties at a very early stage of malignancy in this invasive prostate cancer cell line.
In conclusion, this study indicates that at least
We thank the Center of Nanoimaging, Faculty of Science, Mahidol University for providing accessible and advice to confocal laser scanning microscope usage.
Conceptualization: KJ, VL. Data acquisition: KJ, SM. Data analysis or interpretation: KJ. Drafting of the manuscript: KJ. Critical revision of the manuscript: KJ, VL. Approval of the final version of the manuscript: all authors.
No potential conflict of interest relevant to this article was reported.